Pfizer.Inc is one of the biggest pharmaceutical and biotechnology corporations in the US. The company develops and produces medicines and vaccines, and it has multiple blockbuster drugs and other products, each of which generates over $1 billion in annual revenues.
Around 50% of the firm’s profits are coming from the United States, 8% from China and Japan, while the rest comes from other countries, bolstering people’s preference to buy Pfizer stocks at the current stage.
5 Providers that match your filters
Cost per trade
Fees per trade
67% of retail investor accounts lose money when trading CFDs with this provider.
78.77% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider.
83% of retail investor accounts lose money when trading CFDs with this provider.
There is no guarantee you will make money with this provider. Your capital is at risk.
AvaTrade is a great option, if you want to trade forex, CFDs, and popular cryptos with competitively low spreads and no commissions then . Clients have unfettered access to a demo account as well as the MT4 and MT5 series of platforms.
In This Guide
If you are interested in buying Pfizer stocks, that is quite understandable. The company has seen an excellent price-performance of its shares in 2021, and since the share price has corrected in late summer and early fall, many expect it to soon surge again. So, if you want to buy the shares of Pfizer, we recommend using eToro and following the next four steps.
67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.
If you wish to buy Pfizer stocks, you will first need to find a good stock broker. That might be harder than it sounds at first, given how many stock brokers there are out there, and they all claim to be the best. Of course, there are several good ones, and after a thorough examination, we found two that topped all others.
The first of the two stock brokers that we would recommend is eToro, which is also one of the most popular platforms of this type in the world. Etoro has been around since 2007, and during that time, it delivered excellent service.
There are plenty of reasons why traders prefer this platform over all others, such as the fact that it is regulated by some of the most reliable and trustworthy regulatory bodies in the entire world, including the FCA, CySEC, ASIC, and FINRA. It is very secure and reliable, and it offers over 2,500 investment instruments such as ETFs, shares (e.g. Apple), crypto, etc.
Best of all, you can buy any of them with zero commission, and only have to pay spreads, which are also quite low. eToro has also attracted over 20 million users due to the fact that its minimum deposit is only $50, which makes it available and usable to pretty much everyone who wishes to trade. The platform itself is user-friendly, and meant for novice investors, which means that it is easy to navigate even if you have never been on a broker service’s website before.
Finally, eToro also offers users an easy way to earn profits, even without previous trading experience, and that is through the use of copy-trading. Copy-trading is a feature of social trading, and it allows users to find a trader that deals in the same asset that they are interested in, and then copy their moves. Provided that you have found a true expert, you can mirror his moves in real-time and make a profit even if you personally don’t know what you are doing, or why.
Of course, no matter if you’re a beginner or not, it is always recommended that you educate yourself on the ways of the trading industry, and particularly on the asset that you are trading first.
Other than eToro, we can also recommend using Capital.com. This is a broker based in the UK, which means that it is also regulated by the FCA. However, it is also regulated by CySEC. Capital.com is another popular broker, although much smaller than eToro itself. Its own trader count is at around 360,000, which is still pretty good.
This broker is popular because it doesn’t charge fees on buying, selling, deposits, or withdrawals. Meanwhile, it offers access to even more assets than even eToro. There are more than 3,000 global stock markets listed on its platform, with Pfizer, naturally, being one of them.
Capital.com also offers CFDs, and it has margin trading available, so there is quite a bit to do. The platform itself is easy to navigate, and it has advanced technology, as well as a massive knowledge base that features various educational materials, guides, online courses, and more, all there for the traders’ convenience and easy introduction to trading.
Finally, the platform also has an extremely low minimum deposit of only £20, which is even lower than what eToro offers.
76.25% of retail investor accounts lose money trading CFDs with this provider.
Now that you know where to buy Pfizer stocks, your next objective is to educate yourself about the stock and figure out whether or not it is a good investment, as well as when might be the right time to buy it according to market data. If you wish to perform a long-term investment strategy, then you can invest at pretty much any time.
However, if you wish to buy it for the purpose of trading, then timing is one of the most important things. With that in mind, here is what you need to remember to look into when it comes to the PFE stocks, as well as any other that you may want to engage with.
As investment advice, before investing in any stock, first, be sure to know what the company that the stock belongs to is all about. In Pfizer’s case, this is a US-based pharmaceutical and biotechnological corporation that operates around the world. It has been around for over 170 years now, and it is quite reputable. It is best known for creating medicines and vaccines for immunology, cardiology, neurology, oncology, and endocrinology.
These days, however, most people know the company for its COVID-19 vaccine, which has been distributed and used around the world in order to save the lives of all those willing to protect themselves from the virus that has been plaguing the world for over a year and a half at this point.
Speaking of Pfizer’s stock price, it currently (October 29th, 2021) sits at $43.18 per share, after growing by 0.49% in the last 24 hours. The company’s stock saw a significant price drop between January 2020 and March 2020, sinking from $38.38 to $27.48. However, following the rise of the COVID-19 pandemic and the firm’s work on the vaccine, the market price has not only recovered to previous heights but even surged to a new all-time high.
The last time that Pfizer even came close to these levels was in March of 1999 and then again in June 2000. The company was then spiraling down for 9 years, hitting its bottom in February 2009. After that, it has been growing steadily for over a decade, only to once again skyrocket in 2021 and hit the mentioned ATH of $50.42 per share on August 17th of this year.
Pfizer reported that 2020 was a year like no other in the company’s entire history. It was defined by bold decisions, and even bolder actions and the firm was pleased to report achieving some incredible results. This was a year when it separated from Upjohn, which did make it 20% smaller, but it was more focused on delivering the top products for its patients.
While the company takes great pride when it comes to its vaccine, it noted that this is far from the only thing that it has worked on in 2020. Of course, the vaccine itself is a result of its collaboration with BioNTech, so Pfizer had researchers and resources to dedicate to other pursuits, as well.
From a financial standpoint, the year has been challenging for everyone, and the entire business environment has suffered greatly. Even so, the company noted that it was successful in generating 8% operational revenue growth from its biopharmaceutical product portfolio, and that is excluding the results of the divested Upjohn business, as well as the revenue impact from Consumer Healthcare, and $154 million of sales of the Pfizer-BioNTech COVID-19 vaccine.
A lot of investors tend to go after dividend stocks when investing in order to secure some passive income that will allow their money to make more money. This can then be used for further investments or some other purpose.
While biotech companies typically do not have dividend yields as they simply do not see that big of a cash flow, Pfizer actually does have quarterly dividends for its stockholders, which equate to an annualized dividend rate of $1.56 per share.
Institutional investors interested in company stocks also always check out their ESG (Environmental, Social, Governance), which is known to have a large impact on the stock price. Pfizer has consistently supported and prioritized its ESG-related commitments and programs according to the company’s CEO and Chairman, Dr Albert Bourla.
He added that 2020 marked an important inflection point regarding the role of corporations in modern society and that Pfizer was the one to step up and take the lead, which is something that Dr. Bourla is personally very proud of.
Before we switch to the actual Pfizer stock forecast, note that this is just speculation and that nobody can predict the future results or the way the stock price will move with any certainty because of volatility and other factors. With that said, analysts are predicting a median target of $46 for Pfizer as a 12-month forecast, with a high estimated at $61 and a low estimated at $39. Whether Pfizer’s price goes for the high or median price target, investors will make profits given its current position at $43.
In other words, chances are that Pfizer price will continue its recovery from the drop it saw between August and October of this year, head towards its ATH, and maybe even reach a new one in months to come.
Pfizer’s COVID vaccine came in partnership with BioNTech, which the two companies entered back in 2020. Under the healthcare threat of COVID-19, the firms decided to join forces and work on creating a vaccine together, even though these days, the vaccine is known only as “the Pfizer vaccine,” and the other company name was left out.
Together, the two companies managed to develop a vaccine that offers a 95% efficiency in preventing coronavirus, and protection was successfully confirmed at least 7 days after the patient receives the second dose.
Another important thing to note is that this is the first mRNA vaccine that was ever authorizer in the UK. Only days after the UK gave it green light, the US did the same, followed by Canada, and then Switzerland, as well as other countries. Before long, the so-called Pfizer vaccine traveled around the world, being implemented in treatments all over the globe, alongside the other ones.
Its official name is BNT162b2, it requires 2 shots that are 21 days apart, and it is recommended that moderately to severely immunocompromised patients receive the 3rd dose as well, at least 28 days after receiving the second one. Other people are recommended to receive the third dose as well, although only after six months passes from their 2nd shot.
The last question to answer is whether or not Pfizer is a good buy. Should you buy Pfizer stocks?
Unfortunately, that is not something that anyone can decide, other than investors and traders themselves. What we can recommend, however, is that you do your research, look into all the aspects that we mentioned, such as price performance in the past, price predictions for the future, the impact of its vaccine, the ESG results, and alike, and make a decision based on that.
The company’s stock has been going up for over a decade now, and this drop seen in August 2021 is the largest one since 2009. However, the company is already recovering from it, and it is not impossible for it to reach its former ATH, and maybe even hit a new one, given that its vaccine has been rather successful and that the need for a booster shot is putting the company back under the spotlight.
The last step is to finally make your move and buy Pfizer stock, and to do that, you need to follow only four steps.
The first step is to create a free account on eToro, which you can do by going to its website and signing up. eToro is making this step extremely simple by allowing those who own Facebook and Google account to log in with these services, and not have to create a brand new account from scratch.
67% of retail investor accounts lose money when trading CFDs with this provider.
The next step is to verify your identity, which you need to do for your own protection. eToro has to request that you provide documents that would confirm who you are because that is one of the terms of the standing regulations. However, this also protects you, as someone trying to steal your identity and pose as you would not be able to do the same.
In order to verify your identity, you need to upload a photo of your ID, driver’s license, or passport. In addition to that, eToro also needs you to provide a bank statement that is not older than 3 months.
Once your brokerage account is created and verified, your next step is to load it with some money. This will be the money that you will use as your initial investment, and hopefully, through some careful trades, you will soon make a lot more, and be able to cover the cost of the initial amount, as well as exceed it and make some actual profits. On eToro, you can deposit as little as $50 and start your stock trading with that, which should currently be enough to buy a single stock of Pfizer.
Lastly, all that remains is to use the money that should be on the platform by now and start buying Pfizer stocks. You can find it easily by using the search function at the top of the screen. Simply type in “Pfizer” of “PFE” and you will find it in seconds.
After that, click the Trade button, fill in your order, and hit the Trade button again.
Judging from everything seen in our research of Pfizer, it is quite clear that the company is attracting a lot of attention and that it has managed to thrive under the very difficult circumstances seen in 2020 and 2021. The COVID-19 pandemic is still far from over, but Pfizer has been making gains, and it even hit a new ATH during this time, even though it has been around for over 170 years.
With that said, and with predictions for the future being rather optimistic, we believe that there is potential in buying the stock. Even so, it is up to every investor to come up with their own opinion and make the move they think is right.
Pfizer stock has seen excellent price performance over the last several months, and the company has been performing well for over a decade now. With its COVID-19 vaccine being one of the best-known ones in the world, the firm has everything, from a long history of being reliable and trustworthy to popularity for providing a vaccine that can save lives around the globe.
Pfizer is a multinational pharmaceutical and biotechnology corporation from the United States of America.
As a publicly-traded company, Pfizer is owned by its shareholders, the largest of which are mutual funds.
Pfizer is an American pharmaceutical and biotech company headquartered in New York City.
At the time of writing (October 29th, 2021) Pfizer’s stock price is $43.18 per share.
Pfizer stock has been advancing rapidly over the past year and a half, since developing a vaccine for the COVID-19 pandemic. It did see a correction between August and early October 2021, but it is once again recovering and starting a new surge.
The best way to buy Pfizer stocks is to use eToro’s platform and purchase the stock with zero commission.
Ali is an experienced writer covering the cryptocurrency markets and the blockchain industry. He has 8 years of experience writing about cryptocurrencies, technology, and trading. His work can be found in various high-profiled investment sites including CCN, Capital.com, BeInCrypto, Bitcoinist, and NewsBTC.
Best UK Stock, Forex, CFD, Crypto, Social or Day Trading Platform that meets your needs.